Fallo F, Chouman M, Pagotto U, Pistorello M
Institute of Semeiotica Medica, University of Padova, Italy.
Miner Electrolyte Metab. 1991;17(3):185-9.
The effect of captopril on the aldosterone response to potassium was studied in 6 patients with idiopathic adrenal hyperplasia (IAH) and in 4 patients with an aldosterone-producing adenoma (APA), who all have suppressed activity of circulating renin-angiotensin system (RAS). Precaptopril, KCl infusion induced a significant increase in aldosterone in both groups. This increment was significantly blunted by captopril in IAH, but not in APA. Decreased potassium-stimulated aldosterone secretion after captopril in IAH supports the hypothesis that adrenal RAS plays a role in aldosterone production under potassium stimulation.
在6例特发性肾上腺增生(IAH)患者和4例醛固酮瘤(APA)患者中研究了卡托普利对醛固酮对钾反应的影响,这些患者的循环肾素-血管紧张素系统(RAS)活性均受到抑制。在使用卡托普利前,静脉输注氯化钾可使两组患者的醛固酮显著增加。卡托普利可显著减弱IAH患者的这一增量,但对APA患者无此作用。IAH患者在使用卡托普利后钾刺激的醛固酮分泌减少,支持了肾上腺RAS在钾刺激下醛固酮生成中起作用这一假说。